PKU GOLIKE® is a commercial ultra-rare disease medical formula complementary to Eton's existing metabolic franchise and s...

Here's a roundup of top developments in the biotech space over the last 24 hours:

The biotech sector is poised to end June on a positive note, despite largely disappointing regulatory decisions scheduled durin...

Citing the need to inspect a third-party contract packaging manufacturer, the U.S. Food and Drug Administration (FDA) has issue...

Biotech stocks reversed course along with the broader market and closed the week ending June 3 lower. The sector's lean run...

May turned out to be a month of mixed fortunes as far as regulatory reviews are concerned. New molecular entity approvals, an i...

Here's a roundup of top developments in the biotech space over the last 24 hours: